Miriam M Treggiari MD

Anesthesiology•New Haven, CT

Professor, Anesthesiology, University of Washington School of Medicine

Join to View Full Profile

333 Cedar StNew Haven, CT 06510
Phone+1 203-785-2802
Fax+1 203-785-6664

Summary

Dr. Miriam Treggiari, MD is a board certified anesthesiologist in New Haven, Connecticut. She is currently licensed to practice medicine in Connecticut, North Carolina, and Oregon. She is affiliated with UW Medicine/Harborview Medical Center and Duke University Hospital.

Education & Training

University of Pavia Faculty of MedicineClass of 1990

Certifications & Licensure

NC State Medical License 2022 - 2025
OR State Medical License 2018 - 2025
CT State Medical License 2019 - 2022
AK State Medical License 2014 - 2018
WA State Medical License 2003 - 2015
American Board of Anesthesiology Anesthesiology

Clinical Trials

Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis Start of enrollment: 2004 Sep 01
Completed
Phase 2
Sedation in the Intensive Care Unit Start of enrollment: 2003 Feb 01
Unknown status
Phase 3
Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Start of enrollment: 2009 Apr 01
Terminated
Phase 2
Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury Start of enrollment: 2009 Aug 01
Completed
Phase 1
Intensive Management of Pressure and Volume Expansion in Patients With Subarachnoid Hemorrhage Start of enrollment: 2010 Apr 01
Completed
Phase 1
Endotracheal Tubes for Prevention of Ventilator-associated Pneumonia Start of enrollment: 2012 Dec 01
Completed
Not Applicable
Safety and Efficacy of Acute Normovolemic Hemodilution in Pediatric Cardiac Surgery Patients Start of enrollment: 2016 Jun 30
Active, not recruiting
Not Applicable
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia Start of enrollment: 2019 May 06
COMPLETED
PHASE2
SPI-1005 Treatment in Severe COVID-19 Patients Start of enrollment: 2021 Aug 27
Enrolling by invitation
Phase 2
SPI-1005 Treatment in Moderate COVID-19 Patients Start of enrollment: 2021 Oct 12
Enrolling by invitation
Phase 2
Join now to see all

Publications & Presentations

PubMed

Protocol and design of the REPOSE study: a double-blinded, randomised, placebo-controlled trial to evaluate the efficacy of suvorexant to improve postoperative sleep a...
John Michael Fallon, Mona Hashemaghaie, Christy E Peterson, Dieplinh Tran, Sophie R Wu
BMJ Open. 2025-03-13
Association of Causative Pathogens With Acute Kidney Injury in Adult Patients With Community-Onset Sepsis.
Praruj Pant, Shingo Chihara, Vijay Krishnamoorthy, Miriam M Treggiari, Julia A Messina
Critical Care Explorations. 2025-02-01
Design and implementation of community consultation for research conducted under exception from informed consent regulations for the PreVent and the PreVent 2 trials: ...
Tom Gugel, Karen Adams, Madelon Baranoski, N David Yanez, Michael Kampp
Clinical Trials. 2024-12-01

Press Mentions

The Effectiveness of Ketamine in Pediatric Acute Deafferentation Pain After Spinal Cord InjuryOctober 19th, 2020
The Effectiveness of Ketamine in Pediatric Acute Deafferentation Pain After Spinal Cord InjuryOctober 19th, 2020